tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

XFOR Stock Latest News

Biotech Alert: Searches spiking for these stocks today
The FlyBiotech Alert: Searches spiking for these stocks today
6d ago
RNA
AGEN
X4 Pharmaceuticals price target lowered to $1.50 from $5 at H.C. Wainwright
PremiumThe Fly
X4 Pharmaceuticals price target lowered to $1.50 from $5 at H.C. Wainwright
8d ago
XFOR
X4 Pharmaceuticals Reports Positive Trial Results and Progress
PremiumCompany Announcements
X4 Pharmaceuticals Reports Positive Trial Results and Progress
8d ago
XFOR
X4 Pharmaceuticals price target lowered to $4 from $5 at Stifel
PremiumThe Fly
X4 Pharmaceuticals price target lowered to $4 from $5 at Stifel
8d ago
XFOR
X4 Pharmaceuticals: Promising Phase 2 Trial Results
PremiumCompany Announcements
X4 Pharmaceuticals: Promising Phase 2 Trial Results
8d ago
8K
XFOR
X4 Pharmaceuticals reports Q3 EPS (18c), consensus (17c)
PremiumThe FlyX4 Pharmaceuticals reports Q3 EPS (18c), consensus (17c)
9d ago
XFOR
X4 reports data from Phase 2 clinical trial evaluating mavorixafor
Premium
The Fly
X4 reports data from Phase 2 clinical trial evaluating mavorixafor
9d ago
XFOR
XFOR Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
XFOR Earnings this Week: How Will it Perform?
11d ago
XFOR
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
OCX
BPTH
X4 Pharmaceuticals Unveils Corporate Presentation for Investors
PremiumCompany Announcements
X4 Pharmaceuticals Unveils Corporate Presentation for Investors
3M ago
8K
XFOR
X4 Pharmaceuticals reports Q2 EPS 45c, consensus 1c
PremiumThe Fly
X4 Pharmaceuticals reports Q2 EPS 45c, consensus 1c
4M ago
XFOR
X4 Pharmaceuticals Updates Corporate Presentation for Investors
PremiumCompany Announcements
X4 Pharmaceuticals Updates Corporate Presentation for Investors
4M ago
8K
XFOR
X4 Pharmaceuticals selloff brings opportunity, says H.C. Wainwright
PremiumThe FlyX4 Pharmaceuticals selloff brings opportunity, says H.C. Wainwright
5M ago
XFOR
X4 Pharmaceuticals Advances CN Treatment with Mavorixafor Trials
Premium
Company Announcements
X4 Pharmaceuticals Advances CN Treatment with Mavorixafor Trials
5M ago
8K
XFOR
X4 Pharmaceuticals’ mavorixafor shows efficacy in chronic neutropenia
Premium
The Fly
X4 Pharmaceuticals’ mavorixafor shows efficacy in chronic neutropenia
5M ago
XFOR
X4 Pharmaceuticals announces $125M capital infusion
PremiumThe Fly
X4 Pharmaceuticals announces $125M capital infusion
7M ago
HTGC
XFOR
X4 Pharmaceuticals Advances with Strategic Financial Moves
PremiumCompany Announcements
X4 Pharmaceuticals Advances with Strategic Financial Moves
7M ago
8K
XFOR
X4 Pharmaceuticals reports Q1 EPS (26c), consensus (16c)
PremiumThe Fly
X4 Pharmaceuticals reports Q1 EPS (26c), consensus (16c)
7M ago
XFOR
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
7M ago
ALT
APLS
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
7M ago
ALT
AQST
X4 Pharmaceuticals price target raised to $5 from $3 at H.C. Wainwright
Premium
The Fly
X4 Pharmaceuticals price target raised to $5 from $3 at H.C. Wainwright
7M ago
XFOR
X4 Pharmaceuticals’ Xolremdi approved for WHIM syndrome, says Cantor Fitzgerald
Premium
The Fly
X4 Pharmaceuticals’ Xolremdi approved for WHIM syndrome, says Cantor Fitzgerald
7M ago
XFOR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >